Heated intraperitoneal mitomycin C infusion treatment for patients with gastric cancer and peritoneal metastasis
The vast majority of peritoneal carcinomatosis occurs in the form of a secondary metastatic lesion. In Japan, the stomach is the most frequent origin of metastatic cancer in the abdominal cavity, while in Western countries the ovary is usually affected. The bile duct, large intestine, and breast are other primary sites. With cancerous invasion of the peritoneoserosal membrane, ascitic fluid frequently accumulates in the abdominal cavity and a terminal state can be thus identified.
KeywordsCatheter Lactate Heparin MgCl Oncol
Unable to display preview. Download preview PDF.
- 2.Dedrick RL, Flessner MF, Collins JM, Schultz JS. Is the peritoneum a membrane? ASAIO J 1982;5:1–8.Google Scholar
- 6.Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Takahashi M, Okui K. Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far-advanced or recurrent gastric cancer. Reg Cancer Treat 1989;2:198–202.Google Scholar
- 8.Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Ohta M, Takahashi M, Kitsukawa Y, Mizutani M, Chikenji T, Okui K. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1990;212:592–596.PubMedCrossRefGoogle Scholar
- 9.Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Takahashi M, Okui K. Clinical outcome of combined therapy of intraoperative hyperthermochemotherapy and surgery for patients with peritoneal recurrence from gastric cancer. Reg Cancer Treat 1990;3:181–184.Google Scholar
- 12.Fujimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, Sugiyama K, Hasagawa H, Katayama K, Miwa K, Miyazaki I. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65–71.PubMedCrossRefGoogle Scholar
- 16.Wangensteen OH, Lewis FJ, Tongen LA. The second-look in cancer surgery. Lancet 1951;71:303–307.Google Scholar